Geographic Atrophy Treatment Evaluation

Summary

The purpose of this study was to evaluate the safety and efficacy of AL-8309B Ophthalmic Solution versus Vehicle administered as a topical ocular drop for the treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Timeline

Start

2009-04

Primary completion

2012-05

Completion

2012-05

Outcome

Outcome not reported

Stopped: “Treatment ineffective”

Drugs

Indications